149 related articles for article (PubMed ID: 29055786)
1. Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury.
Segersvärd H; Lakkisto P; Hänninen M; Forsten H; Siren J; Immonen K; Kosonen R; Sarparanta M; Laine M; Tikkanen I
Eur J Pharmacol; 2018 Jan; 818():57-66. PubMed ID: 29055786
[TBL] [Abstract][Full Text] [Related]
2. [Protective effect of carbon monoxide releasing molecules 2 on post-resuscitation myocardial dysfunction in rats].
Liu M; Wang F; Liu F; Du F; Wang XH
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):311-317. PubMed ID: 31060191
[No Abstract] [Full Text] [Related]
3. Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts.
Zhang W; Tao A; Lan T; Cepinskas G; Kao R; Martin CM; Rui T
Basic Res Cardiol; 2017 Mar; 112(2):16. PubMed ID: 28168403
[TBL] [Abstract][Full Text] [Related]
4. [Effects of carbon monoxide release molecule-2 on sepsis-induced myocardial dysfunction in rats].
Zhang S; Qi W; Wang F; Xu Y; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1097-1101. PubMed ID: 31657332
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide releasing molecule‑2 attenuated ischemia/reperfusion‑induced apoptosis in cardiomyocytes via a mitochondrial pathway.
Zhao S; Lin Q; Li H; He Y; Fang X; Chen F; Chen C; Huang Z
Mol Med Rep; 2014 Feb; 9(2):754-62. PubMed ID: 24337106
[TBL] [Abstract][Full Text] [Related]
7. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3).
Musameh MD; Green CJ; Mann BE; Fuller BJ; Motterlini R
J Heart Lung Transplant; 2007 Nov; 26(11):1192-8. PubMed ID: 18022087
[TBL] [Abstract][Full Text] [Related]
8. Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).
Filippo CD; Perretti M; Rossi F; Ferraraccio F; Motterlini R; D'Amico M
Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):137-44. PubMed ID: 22038495
[TBL] [Abstract][Full Text] [Related]
9. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats.
Chen P; Sun B; Chen H; Wang G; Pan S; Kong R; Bai X; Wang S
Cytokine; 2010 Jan; 49(1):15-23. PubMed ID: 19900821
[TBL] [Abstract][Full Text] [Related]
10. CORM-2 inhibits intracerebral hemorrhage-mediated inflammation.
Chen Z; Zhang H; Zhou J; Stone C; Ding Y; Zhang Y; Ren C; Yin X; Meng R
Neurol Res; 2021 Oct; 43(10):846-853. PubMed ID: 34107862
[No Abstract] [Full Text] [Related]
11. The CO-releasing molecule CORM-3 protects adult cardiomyocytes against hypoxia-reoxygenation by modulating pH restoration.
Portal L; Morin D; Motterlini R; Ghaleh B; Pons S
Eur J Pharmacol; 2019 Nov; 862():172636. PubMed ID: 31491405
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats.
Segersvärd H; Lakkisto P; Forsten H; Immonen K; Kosonen R; Palojoki E; Kankuri E; Harjula A; Laine M; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):92-102. PubMed ID: 23629679
[TBL] [Abstract][Full Text] [Related]
13. [Effects of exogenous carbon monoxide-releasing molecule 2 intervention in vitro on formation of human neutrophil extracellular traps stimulated by endotoxin/lipopolysaccharide and its mechanism].
Song M; Wang X; Qin W; Zhuang M; Xu X; Zhang Y; Sun B
Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):82-8. PubMed ID: 26902274
[TBL] [Abstract][Full Text] [Related]
14. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
15. Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
Iqbal J; Chamberlain J; Alfaidi M; Hughes M; Alizadeh T; Casbolt H; Evans P; Mann B; Motterlini R; Francis S; Gunn J
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e656-e661. PubMed ID: 34328710
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
17. Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced COX-2 expression and hypertrophy in primary human cardiomyocytes.
Chien PT; Lin CC; Hsiao LD; Yang CM
Toxicol Appl Pharmacol; 2015 Dec; 289(2):349-59. PubMed ID: 26385185
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney.
Bagul A; Hosgood SA; Kaushik M; Nicholson ML
Transplantation; 2008 Feb; 85(4):576-81. PubMed ID: 18347537
[TBL] [Abstract][Full Text] [Related]
19. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
Liu D; Zhuang M; Zhang J; Chen J; Sun B
Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
[TBL] [Abstract][Full Text] [Related]
20. The severity of microvascular dysfunction due to compartment syndrome is diminished by the systemic application of CO-releasing molecule-3.
Lawendy AR; Bihari A; Sanders DW; Potter RF; Cepinskas G
J Orthop Trauma; 2014 Nov; 28(11):e263-8. PubMed ID: 24675751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
